The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction

Molecular Human Reproduction

Volumn 10, Issue 2, 2004, Pages 99-108

  Clark, David ^a,b,c,f   Foerster, Katharina ^a,d   Fung, Laisum ^b   He, Wei ^b   Lee, Lydia ^b   Mendicino, Michael ^b   Markert, Udo R ^d   Gorczynski, Reginald M ^b,c   Marsden, Philip A ^b,c,e   Levy, Gary A ^b,c  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f NONE   (Canada)

Author keywords

Bacterial lipopolysaccharide; fgl2 prothrombinase; Fibroleukin; Haemostasis in pregnancy; Spontaneous abortion

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; CYTOKINE; PROTEIN ANTIBODY;

ABORTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BLEEDING; CONTROLLED STUDY; DECIDUA; DISEASE ASSOCIATION; EMBRYO DEATH; EMBRYONAL TISSUE; ENZYME ACTIVITY; FEMALE; FETUS; GENE MUTATION; GENOTYPE; GESTATIONAL AGE; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MATING; MOTHER; MOUSE; MOUSE STRAIN; NONHUMAN; OUTBRED STRAIN; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RECURRENT DISEASE; REPRODUCTION; SPONTANEOUS ABORTION; TIME; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANIMALS; EMBRYO; FEMALE; FIBRINOGEN; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; MICE, KNOCKOUT; REPRODUCTION; UTERUS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 1042303514     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah013     Document Type: Article

References (47)

1. Amory JH, Hitti J, Lawler R and Eschenbach DA (2001) Increased tumor necrosis factor-α production after lipopolysaccharide stimulation of whole blood in patients with previous preterm delivery complicated by intra-amniotic infection or inflammation. Am J Obstst Gynecol 185,1064-1067.
2. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EW el al, (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 93,6258-6263.
3. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrand P et al. (1996a) Role of tissue factor in embryonic blood vessel development. Nature 383,73-75.
4. Carmeleit P, Ferreira V, Breier G, Pollefeyt S, Kleckens L, Gerstsenstein M, Fahrig M, Vandenhoeck A, Harpal M, Eberhardt C et al. (1996b) Abnormal blood vessel development in embryos lacking a single VEGF allele. Nature 380,435-438.
5. Chan CWY, Chan MWC, Liu M, Fung L, Cole EH, Leibowitz JL, Marsden PA, Clark DA and Levy GA (2002) Kinetic analysis of a unique direct prothrombinase, fgl2, and the identification of a serine residue critical for the prothrombinase activity. J Immunol 168,5170-5177.
6. Chan CWY, Kay LS, Khadaroo RG, Chan MWC, Lokatoo S, Young KJ, Zhang L, Gorczynski RM, Cattral M, Rotstein O et al. (2003) Soluble fgl2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and preventing maturation of bone marrow-derived dendritic cells. J Immunol 170,4036-4044.
7. Chaouat G (1994) Synergy of lipopolysaccharide and inflammatory cytokines in marine pregnancy: alloimmunization prevents abortion but does not affect the induction of preterm delivery. Cell Immunol 157,328-340.
8. Chaouat G and Menu E (1997) Maternal T cell reactivity in pregnancy. Curr Top Microbiol Immunol 222,103-126.
9. Clark DA (1999) Hard science versus phenomenology in reproductive immunology. Crit Rev Immunol 19,509-539.
10. Clark DA (2003) Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? J Assist Reprod Genet 20,63-72.
11. Clark DA, Banwatt D and Chaouat G (1993) Stress-triggered abortion in mice is prevented by alloimmunization. Am J Reprod Immunol 29,141-147.
12. Clark DA, Chaouat G, Arck PC, Mittruecker HW and Levy GA (1998) Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J Immunol 160,545-549.
13. Clark DA, Ding JW, Chaouat G, Coulant CB, August C and Levy GA (1999a) The emerging role of immunoregulation of fibrinogen-related procoagulant fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod mammal 42,37-43.
14. Clark DA, Arck PC and Chaouat G (1999b) Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 41,5-22.
15. Clark DA, Ding JW, Yu G, Levy CA and Gorczynski RM (2001a) Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod 7,185-194.
16. Clark DA, Yu G, Levy GA and Gorczynski RM (2001b) Procoagulants in fetus rejection: the role of the OX-2 (CD200) tolerance signal. Semin Immunol 13,255 263.
17. Clark DA, Yu G, Arck PC, Levy GA and Gorczynski RM (2003a) MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol 49,297-307.
18. Clark DA, Keil A, Chen Z, Markert U, Manuel J and Gorczynski RM (2003b) Placental trophoblast from successful human pregnancies expresses the tolerance signalling molecule CD200 (OX-2). Am J Reprod Immunol 50,187-195.
19. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr and Coughlin SR (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381,516-519.
20. Coulam CB and Roussev R (2002) Chemical pregnancies: immunological and ultrasonographic studies. Am J Reprod Immunol 48,323-328.
21. Cui J, O'Shea S, Purkayastha A, Saunders TL and Ginsburg D (1996) Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384,66-68.
22. Darrow AL, Fung-Leung W-P, De RY, Santulli J, Cheung W-M, Derian CK, Burns CL, Damiano BP, Zhou L, Keenan CM et al. (1996) Biological consequences of thrombin receptor deficiency in mice. Thromb Hemost 76,860-866.
23. Dewerchin M, Liang Z, Moons L, Carmeliet P, Castellino FJ, Collen D and Rosen ED (2000) Blood coagulation factor X deficiency causes perinatal embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 83,185-190.
24. Ding JW, Ning Q, Liu MF, Lai A, Leibowitz J, Peltekain KM, Cole EH, Fung LS, Holloway C, Marsden PA et al. (1997) Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue specific expression of a novel fgl2 prothrombinase. J Virol 71,9223-9230 [erratum (1998) J Virol 72,3504].
25. Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan, KL and Moore, MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380,439-442.
26. Erlich J, Parry GCN, Fearns C, Muller M, Carmeliet P, Luther T and Mackman N (1999) Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci USA 96,8138-8143.
27. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KL and Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380,439-442.
28. Ferrara N, Carver-Moore K, Chen H, Ghazeeri GS, Clark DA and Kutteh WH (2001) Immunologic factors in implantation. Infertil Reprod Med Clin N Amer 12,315-337.
29. Ghazeeri GS, Clark DA and Kutteh WH (2001) Immunological factors in implantation. Infertil Reprod Med Clin N Amer 12,315-337.
30. Healy AM, Rayburn HB, Rosenberg RD and Weiler H (1995) Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 92,850-854.
31. Iwaki T, Sandoval-Coope MJ, Palva M, Kobayashi T, Ploplis VA and Castellino FJ (2002) Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 160,1021-1034.
32. Kaga N, Katsuki Y, Obata M and Shibutani Y (1996) Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstst Gynecol 174,754-759.
33. Knackstedt M, Ding JW, Arck PC, Hertwig K, Coulam CB, August C, Lea R, Dudenhausen JW, Gorczynski RM, Levy GA et al. (2002) Activation of a novel prothrombinase, fgl2, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 46,196-210.
34. Levy GA, Liu M, Ding J, Yuwaraj S, Leibowitz J, Marsden PA, Ning Q, Kovalinka A and Phillips MJ (2000) Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol 156,1217-1225.
35. Marazzi S, Blum S, Hartman R, Gundersen D, Schreyer M, Argraves S, von Fliedner V, Pytela R and Ruegg C (1998) Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 161,138-147.
36. Marsden PA, Ning Q, Fung LS, Luo XP, Chen Y, Mendicino M, Ghanekar A, Scott JA, Miller T, Chan C et al. (2003) The fgl2/fibroleukin prothrombinase contributes to immunologically-mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 112,58-66.
37. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D and Munn DH (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunol 2,64-68.
38. Pan VL, Goharkhay N, Felix JC and Wing DA (2003) FGL2 prothrombinase messenger RNA expression in gravid and nongravid human myometrium. Am J Obstst Gynecol 188,1057-1062.
39. Parry GCN, Erlich JH, Carmeliet P, Luther T and Mackman N (1998) Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 101,560-569.
40. Ploplis VA, Wilberding J, McLennan L, Liang Z, Cornelissen I, DeFort ME, Rosen ED and Castellino FJ (2000) A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol 157,703-708.
41. Rosen ED, Chan JCY, Idusogie E, Clotman F, Vlasuk G, Luther T, Jalbert LR, Albrecht S, Zhong L, Lissens A et al. (1997) Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 390,290 294.
42. Snedecor GW and Cochrane WG (1971) Statistical Methods, 6th edn, Iowa State University Press, Ames, pp. 228-231.
43. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter SS and Degen JL (1995) Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9,2020-2033.
44. Sun WY, Witte DP, Degen JL, Colbert MC, Burkart MC, Holmback K, Xiao Q, Bugge TH and Degen SJF (1998) Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 95,7597-7602.
45. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ and Broze GJ Jr (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88,1583-1587.
46. Weiler-Guettler H, Aird WC, Rayburn H, Husain M and Rosenberg RD (1996) Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 122,2271-2281.
47. Xue J, Wu Q, Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X and Sadler JE (1998) Incomplete embryonic lethality and fatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 95,7603 7607.